CU20090014A7 - EP2 AGONISTS - Google Patents

EP2 AGONISTS

Info

Publication number
CU20090014A7
CU20090014A7 CU20090014A CU20090014A CU20090014A7 CU 20090014 A7 CU20090014 A7 CU 20090014A7 CU 20090014 A CU20090014 A CU 20090014A CU 20090014 A CU20090014 A CU 20090014A CU 20090014 A7 CU20090014 A7 CU 20090014A7
Authority
CU
Cuba
Prior art keywords
agonists
compounds
methods
preparation
provides
Prior art date
Application number
CU20090014A
Other languages
Spanish (es)
Inventor
Fontaine Jennifer Anne La
Charles Floyd Bosworth
Ganesh Prasanna
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to CU20090014A priority Critical patent/CU20090014A7/en
Publication of CU20090014A7 publication Critical patent/CU20090014A7/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona agonistas de EP2, procedimientos para su preparación, composiciones farmacéuticas que contienen estos compuestos y procedimientos de uso de estos compuestos y composiciones para reducir la presión intraocular y tratar así el glaucoma.The present invention provides EP2 agonists, methods for their preparation, pharmaceutical compositions containing these compounds and methods of using these compounds and compositions for reducing intraocular pressure and thus treating glaucoma.

CU20090014A 2009-01-27 2009-01-27 EP2 AGONISTS CU20090014A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20090014A CU20090014A7 (en) 2009-01-27 2009-01-27 EP2 AGONISTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20090014A CU20090014A7 (en) 2009-01-27 2009-01-27 EP2 AGONISTS

Publications (1)

Publication Number Publication Date
CU20090014A7 true CU20090014A7 (en) 2011-03-21

Family

ID=44280882

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090014A CU20090014A7 (en) 2009-01-27 2009-01-27 EP2 AGONISTS

Country Status (1)

Country Link
CU (1) CU20090014A7 (en)

Similar Documents

Publication Publication Date Title
GT200700064A (en) EP2 AGONISTS
ECSP12012318A (en) PIRAZOLIL QUINAZOLINA CINASA INHIBITORS
UY31806A (en) TIAZOLE AND OXAZOLE COMPOUNDS OF BENZENE SULFONAMIDE
ECSP11011390A (en) ESPIRO-AMIDAS SUBSTITUTED COMPOUNDS
CL2009000426A1 (en) Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
SV2009003307A (en) QUINAZOLINS FOR THE INHIBITION OF PDK1
NI201100166A (en) BENZOFURANIL DERIVATIVES USED AS GLUCOKINASE INHIBITORS
CR20140161A (en) BENZILINDAZOLS REPLACED FOR USE AS INHIBITORS OF QUINASA BUB1 IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
CR20170384A (en) DERIVATIVES OF USEFUL REPLACED NUCLEOSIDS AS ANTINEOPLASIC AGENTS
CL2012000921A1 (en) Compounds derived from spiropiperidine-methylbenzyloxyphenyl, activators of the rpg-40 receptor; pharmaceutical composition comprising them; and use of the compound to treat diabetes.
CR20110028A (en) PIRIMIDINE DERIVATIVES AS CINASE INHIBITORS
DOP2011000076A (en) DERIVATIVES OF HETEROARIL AMIDAS AND ITS USE AS GLUCOQUINASE ACTIVATORS
CL2014000543A1 (en) Compounds derived from amino substituted imidazopyridazines, kinase inhibitors, mknk2; Preparation method; intermediary compounds and their use; pharmaceutical composition; pharmaceutical combination; and its use for the treatment of cancer.
ECSP099620A (en) SPIROCICLIC CYCLHEXAN DERIVATIVES
CL2011001331A1 (en) Nalmefene Hydrochloride Dihydrate; methods for its preparation; pharmaceutical composition comprising it; and use for the treatment of alcoholism.
CL2012000937A1 (en) Spiro-derived heterocyclic compounds of cyclohexane, hsl inhibitors; preparation procedure; pharmaceutical composition comprising them; use of the compound for the treatment of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis or obesity.
CR20110497A (en) NEW ANTI-ALFA5BETA1 ANTIBODIES AND THEIR USES
CU24263B1 (en) DERIVATIVES OF IMIDAZOPIRIDAZINAS INHIBITORS OF QUINASA AKT, USEFUL FOR THE TREATMENT OF CANCER
NI201400042A (en) 2 - THIOPYRIMIDINONES
CO6341625A2 (en) DERIVATIVES OF INDOL AS ANTI-CANCER AGENTS
CR20160433A (en) NEW COMPOUNDS
BR112015023878A2 (en) compound, pharmaceutical composition, and use of a compound
CL2011000168A1 (en) Compounds derived from narcyclasin and pancratistatin; preparation procedure; pharmaceutical composition; pharmaceutical combination; and its use for the treatment of cancer.
GT201300225A (en) TIENO (2,3-D) DERIVED FROM PIRIMIDINE AND ITS USE FOR THE TREATMENT OF ARRITMIA
AR072426A1 (en) USE OF NIFURTIMOX FOR THE TREATMENT OF DISEASES CAUSED BY TRICOMONADIDA